Sinocelltech announced that its holding subsidiary, Sinocelltech Engineering Co., Ltd., has received the drug clinical trial approval notice from the National Medical Products Administration for its self-developed product SCT640C injection, allowing the clinical trial for adult rheumatoid arthritis indications to proceed
